Lv3
340 积分 2023-10-31 加入
Tislelizumab Plus Platinum and Etoposide Versus Placebo Plus Platinum and Etoposide as First-Line Treatment for Extensive-Stage SCLC (RATIONALE-312): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Clinical Trial
2天前
已完结
Tackling the current dilemma of immunotherapy in extensive-stage small cell lung cancer: A promising strategy of combining with radiotherapy
2个月前
已完结
Low dose ionizing radiation and the immune response: what is the role of non-targeted effects?
5个月前
已完结
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
5个月前
已完结
Radiotherapy and immunotherapy: open questions and future strategies
5个月前
已完结
Exploring low-dose radiotherapy to overcome radio-immunotherapy resistance
5个月前
已完结
低剂量放射超敏感性机制研究及临床应用现状
5个月前
已完结
Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-PD1 in Mice and Patients With Non-Small Cell Lung Cancer
5个月前
已完结
Efficacy and safety of low-dose radiotherapy (LDRT) concurrent atezolizumab plus chemotherapy as first-line therapy for ES-SCLC : Interim analysis of Phase II MATCH trial
5个月前
已关闭
Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer
6个月前
已完结
皖公网安备34019202002308
